Financial reports
ARS
2023 FY
Annual report to shareholders
1 Apr 24
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
Current reports
8-K
Corporate Presentation April 2024
9 Apr 24
8-K
Departure of Directors or Certain Officers
21 Mar 24
8-K
Departure of Directors or Certain Officers
11 Mar 24
8-K
Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results
29 Feb 24
8-K
Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing™ Platform
5 Feb 24
8-K
Quantum-Si Reports Third Quarter 2023 Financial Results
9 Nov 23
8-K
Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors
21 Sep 23
8-K
Departure of Directors or Certain Officers
5 Sep 23
8-K
Cost Associated with Exit or Disposal Activities
29 Aug 23
8-K
Quantum-Si Reports Second Quarter 2023 Financial Results
7 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
29 Feb 24
S-3
Shelf registration
11 Aug 23
S-8
Registration of securities for employees
20 Jul 23
S-8
Registration of securities for employees
16 Mar 23
S-8
Registration of securities for employees
10 Nov 22
424B3
Prospectus supplement
20 Jul 22
424B3
Prospectus supplement
20 Jul 22
POS AM
Prospectus update (post-effective amendment)
15 Jul 22
424B3
Prospectus supplement
16 Jun 22
424B3
Prospectus supplement
16 Jun 22
Proxies
DEFA14A
Additional proxy soliciting materials
1 Apr 24
DEF 14A
Definitive proxy
1 Apr 24
PRE 14A
Preliminary proxy
22 Mar 24
DEFA14A
Additional proxy soliciting materials
29 Mar 23
DEF 14A
Definitive proxy
29 Mar 23
PRE 14A
Preliminary proxy
17 Mar 23
DEFA14A
Additional proxy soliciting materials
29 Mar 22
DEF 14A
Definitive proxy
29 Mar 22
Other
EFFECT
Notice of effectiveness
23 Aug 23
CORRESP
Correspondence with SEC
18 Aug 23
UPLOAD
Letter from SEC
18 Aug 23
EFFECT
Notice of effectiveness
19 Jul 22
EFFECT
Notice of effectiveness
4 Mar 22
EFFECT
Notice of effectiveness
22 Jul 21
CORRESP
Correspondence with SEC
19 Jul 21
UPLOAD
Letter from SEC
8 Jul 21
EFFECT
Notice of effectiveness
17 May 21
CORRESP
Correspondence with SEC
13 May 21
Ownership
4
Paula Dowdy
25 Mar 24
3
Paula Dowdy
25 Mar 24
4
Jeffry R. Keyes
18 Mar 24
4
Jeffrey Alan Hawkins
18 Mar 24
4
Grace Johnston
18 Mar 24
4
Christian LaPointe
18 Mar 24
4
Jeffry R. Keyes
6 Mar 24
SC 13G
Nikko Asset Management Americas, Inc.
13 Feb 24
SC 13G
Sumitomo Mitsui Trust Holdings, Inc.
5 Feb 24
SC 13G/A
BlackRock Inc.
29 Jan 24